Fexuprazan for Prevention of Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy

Clinical trial NCT07479056 · RECRUITING

Trial details

NCT number: NCT07479056
Sponsor: SUK MIN SEO
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Coronary Syndromes (ACS)Coronary Artery Disease (CAD)

Start date: 2024-10-24
Primary completion: 2028-04-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.